Future Market Insights (FMI) projects some key insights on the Global Anti-Counterfeit Pharmaceutical Packaging Market in a new report named, "Anti-counterfeit Pharmaceutical Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2026". The global anti-counterfeit pharmaceutical packaging market is predicted to register a robust CAGR of more than 11.1% during the forecast period 2016-2026. The report provides in-depth information on the global anti-counterfeit pharmaceutical packaging market and talks about the global market behaviour, competitive economy, market drivers, and market width and assess the climate of the market for the next ten years.

The surge in the demand for safe packaging to destroy the nexus of illicit drugs spread across the globe is increasing. The present pharmaceutical economy is poisoned by forged medicines that are available in the market in abundance. The soaring market size of the counterfeit drugs is creating a parallel economy in the global market. The emerging threat has a rippling effect on all the stakeholders and also on the consumers. This dark underbelly of the pharmaceutical industry is crippling the growth of the market. The increasing population of counterfeiting drugs compelled the pharma manufacturers to set up a safety ring to guard them against this threat. Anti-counterfeiting packaging has the ability to unshackle the pharmaceutical industry from the clutches of counterfeit medicines. Pharma companies inducted multiple anti-counterfeit designs to stop the malice. Advanced hologram, water and barcode are mostly used as a regular restrictive measure to stop the emergence of counterfeit medicines. However, with the use of state of the art technology, the pharmaceutical manufacturers have successfully bulldozed this risk. The alarming rise in the need of the anti-counterfeit pharmaceutical packaging is a dawn of a new era. Mushrooming popularity of the Anti-Counterfeit Pharmaceutical packaging technology is affecting the global demand for the Anti-Counterfeit Pharmaceutical packaging.

The WHO and FDA's efforts to ensure safe-conduct practices across the pharmaceutical industry value chain by integrating advanced anti-counterfeit packaging technology encouraged pharma manufacturers to explore new possibilities. This, in turn, is creating value for suppliers of anti-counterfeit packaging technology to the pharmaceutical industry. The anti-counterfeit pharmaceutical packaging market is responding with positive growth rate, which is likely to continue during the period of assessment.

Global anti-counterfeit pharmaceutical packaging is divided as per the usage feature (convert features, evidence and track & trace, tamper feature, divert features, forensic markers, technologies- [identification system and sterilization] and technology (security printing and graphics, RFID- [active tags, passive tags, semi-active tags], security inks and coatings, Mass Encoding-[ Barcode Application, Digital Mass Serialization, Digital Mass Encryption], Hologram, Others- [Electromagnetic, surveillance technologies]).

On the basis of usage feature, track & trace technologies segment will spike and it will account for more than US$ 2,700 million by the end of the prediction period, registering a high CAGR of over 12% over the assessment period. It will occupy more than 35% of the market share by the end of the period of conjecture. Covert feature segment is anticipated to follow closely and to register CAGR of little more than 12% by the end of the period of projection.

The Security Painting and Graphics technology stream of the global anti-counterfeit pharmaceutical packaging market worth in 2015 was 208.9 million. It will continue its growth trail and it is predicted to touch a market worth of more than US$ 7 million by the end of 2026, record a CAGR in excess of 11.5% during the assessment period. The section is likely to develop a cumulative $ opportunity of more than US$ 500 million within the assessment period.

The RFID technology is contributing significantly to the impressive growth in this segment. The Active Tags sub-segment is estimated to account for a market share of 47.5% in 2016, among all other RFID technologies. Furthermore, the sub-segment is anticipated to gain 330 BPS within the projection period.

The report covers the global anti-counterfeit pharmaceutical packaging market across seven key regions namely – North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excl. Japan (APEJ), and the Middle East and Africa (MEA). North America is predicted to dominate the anti-counterfeit pharmaceutical packaging market within the assessment period. Anti-counterfeit pharmaceutical packaging in North America to take a major leap within the forecast period as the active presence of major pharma companies, swelling exports and several biologics research hubs to expedite the market growth.

Anti-counterfeit pharmaceutical packaging market will witness robust growth in the APAC market driven by increasing demand for anti-counterfeit measures in this part of the globe and the market is growing at the CAGR of 18.9 % over the assessment period. Latin America will likely be a rapidly growing market in the coming decade, registering CAGR of over 12%. The new wave of economic reforms in the MEA sector is wooing foreign investors. Africa is an embarking economy which is influencing native and international players. The anti-counterfeit pharmaceutical market in Africa and MEA is projected to stretch at a CAGR of more than 11% by the end of 2026 and the economic revolution in this part of the world will play a vital role.

The report has elaborately listed the leading anti-counterfeit pharmaceutical packaging manufacturers operating in the global anti-counterfeit pharmaceutical packaging market. They are Avery Dennison Corp., Authentix, Sicpa Holdings, CFC international and Applied DNA sciences, 3M trace & trace solution, Alien Technology, Digimarc Impinj Inc, ATL Security Label Systems, Sicpa Holdings.